Oral Bioavailability of GLPG0555 in Different Solid Formulations
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetics of a solid capsule formulation of
GLPG0555 with a nanosuspension, and to assess safety and tolerability of a single dose of
GLPG0555.